Browsing: biopharmaceutical

Avammune Therapeutics, a biopharmaceutical startup, has secured $12 million in its Series A funding round led by Capital 2B, Shastra VC, and Kotak Alternate Asset Managers’ Life Sciences Fund I.

BioVaxys Technology Corp. (BIOV) has received a management cease trade order from the British Columbia Securities Commission following delays in its audited annual financial statements. The company expects to complete the filings by March 30, 2025.